Protective effect of methanolic extract of Garcinia indica fruits in 6-OHDA rat model of Parkinson's disease

Indian Journal of Pharmacology

Volumn 44, Issue 6, 2012, Pages 683-687

  Antala, Bhaveshkumar V ^a   Patel, Manishkumar S ^a   Bhuva, Satish V ^b   Gupta, Shiv ^b   Rabadiya, Samir ^c   Lahkar, Mangala ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER AHMEDABAD   (India)

^c NIRMA UNIVERSITY   (India)

Author keywords

6 OHDA; Garcinia indica; Parkinson's disease

Indexed keywords

APOMORPHINE; CARBOXYMETHYLCELLULOSE; DOPAMINE; GARCINIA INDICA EXTRACT; OXIDOPAMINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CLINICAL ASSESSMENT TOOL; CORPUS STRIATUM; DISENGAGE TIME; DOPAMINERGIC NERVE CELL; GARCINIA; GARCINIA INDICA; INITIATION TIME; MALE; MENTAL TASK; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; POSTURAL BALANCE TEST; RAT; ROTATION; STEPPING TEST; SUBSTANTIA NIGRA; TASK PERFORMANCE;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOPAMINE; FRUIT; GARCINIA; HOMOVANILLIC ACID; MALE; METHANOL; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SOLVENTS;

EID: 84870045565     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.103242     Document Type: Article

References (27)

1. Singh S, Ahmed R, Sagar RK, Krishana B. Neuroprotection of the nigrostriatal dopaminergic neurons by melatonin in hemiparkinsonium rat. Indian J Med Res 2006;124:419-26.
2. The wealth of India, Raw materials. In: Ambasta SP, editor. Vol. 4. New Delhi: Publication and Information Directorate, CSIR; 1998.
3. Dushyantha DK, Girish DN, Suvarna VC, Dushyantha DK. Native lactic acid bacterial isolates of kokum for preparation of fermented beverage. Europ J Biol Sci 2010;2:21-4.
4. Agnivesha. Prameha Chikitsa. In: Charaka Samhita. 5th ed. Varanasi: Chaukhamba Sanskrit Sansthan; 2001.
5. Yamaguchi F, Ariga T, Yoshimura Y, Nakazawa H. Antioxidative and anti-glycation activity of garcinol from Garciniaindica fruit rind. J Agric Food Chem 2000;48:180-5.
6. Tamil Selvi A, Joseph GS, Jayaprakasha GK. Inhibition of growth and aflatoxin production in Aspergillus flavus by Garcinia indica extract and its antioxidant activity. Food Microbiol 2003;20:455-60.
7. Mishra A, Bapat MM, Tilak JC, Devasagayam T. Antioxidant activity of Garcinia indica (kokam) and its syrup. Curr Sci 2006;91:90-3.
8. Miller RL, James-Kracke M, Sun GY, Sun AY. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res 2009;34:55-65.
9. Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G. Non-steroidal anti-inflammatory drugs in Parkinson's disease. Exp Neurol 2007;205:295-312.
10. Khatib NA, Pawase K, Patil PA. Evaluation of anti inflammatory activity of garciniaindica fruit rind extracts in wistar rats. Inter J Res Ayurveda Pharmacy 2010;1:449-54.
11. Amol BD, Vinayak DS, Nilofer SN. Antioxidant and hepatoprotective effect of Garcinia indica Linn fruit rind. Pharmacie Globale (IJCP) 2011;6:1-5.
12. Udia PM, Braide VB, Owu DU. Antispasmodic and spasmolytic effects of methanolic extract from seeds of Garcinia kola on isolated rat small intestine. Niger J Physiol Sci 2009;24:111-6.
13. Okoko T. In vitro antioxidant and free radical scavenging activities of Garcinia kola seeds. Food Chem Toxicol 2009;47:2620-3.
14. Paxinos G, Watson C. In: The rat brain in stereotaxic coordinates. 2nd ed. Sydney: Academic Press; 1986.
15. Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970;24:485-93.
16. Schallert T, De Ryck M, Whishaw IQ, Ramirez VD, Teitelbaum P. Excessive bracing reactions and their control by atropine and L-DOPA in an animal analog of Parkinsonism. Exp Neurol 1979;64:33-43.
17. Olsson M, Nikkhah G, Bentlage C, Björklund A. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 1995;15:3863-75.
18. Winkler C, Sauer H, Lee CS, Björklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 1996;16:7206-15.
19. Sauer H, Oertel WH. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994;59:401-15.
20. Eghwrudjakpor PO, Miyake H, Kurisaka M, Mori K. Central nervous system bioaminergic responses to mechanical trauma: An experimental study. Surg Neurol 1991;35:273-9.
21. Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998;1366:211-23.
22. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 2004;318:215-24.
23. Costa G, Abin-Carriquiry JA, Dajas F. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantianigra. Brain Res 2001;888:336-42.
24. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 2003;53(Suppl 3):S26-36.
25. Adaramoye OA. Protective effect of kolaviron, a biflavonoid from Garcinia kola seeds, in brain of Wistar albino rats exposed to gamma-radiation. Biol Pharm Bull 2010;33:260-6.
26. Farooqui T, Farooqui AA. Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinsons Dis 2011;2011:247467.
27. Liao CH, Ho CT, Lin JK. Effects of garcinol on free radical generation and NO production in embryonic rat cortical neurons and astrocytes. Biochem Biophys Res Commun 2005;329:1306-14.